CC
CNST

Commodore Capital’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Commodore Capital’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-440,869
Closed -$14.9M – 34
2021
Q2 		$14.9M Buy
440,869
+72,421
+20% +$1.85M 5.19% 6
2021
Q1 		$8.62M Sell
368,448
-55,260
-13% -$1.67M 3.43% 11
2020
Q4 		$12.2M Buy
+423,708
New +$10.7M 6.63% 3

Commodore Capital's CNST Position: Q3 2021 in Review

Commodore Capital sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 440,869 shares — an estimated $14.9M sold.

Commodore Capital first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $14.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Commodore Capital reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Commodore Capital sold 440,869 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $14.9M.
  • Commodore Capital first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
  • Commodore Capital's Constellation Pharmaceuticals, Inc. position peaked at $14.9M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Commodore Capital's 13F filing for Q3 2021, filed 15 Nov 2021.